Abstract:To investigate the mechanism of Long Non-coding RNA GAS5 regulating MiR-424 to promote the proliferation of cervical cancer cells. MethodsThe miRNA targeting GAS5 was predicted and screened. The luciferase activity was detected by the dual luciferase method. The mRNA levels of GAS5 and miR-424 in cervical cancer tissue and normal cervical tissue and their relationship with clinicopathological characteristics of patients were analyzed. The mRNA levels of GAS5 and miR-424 were detected in Ect1/E6E7 cells and HeLa cells. The miR-NC, GAS5 RNAi and pCDNA3.0-HA-GAS5 plasmids were transfected into HeLa cells, and the cell proliferation and apoptosis were detected by MTT and flow cytometry, and the Dnmts, EZH2 and Akt3 proteins were detected by Western blotting. ResultsmiR-424 could significantly reduce the luciferase activity of GAS5-WT (P<0.05), indicating that GAS5 and miR-424 have a targeted regulatory effect. The mRNA expressions of GAS5 and miR-424 in cervical cancer tissues were lower than those in normal cervical tissues (P<0.05). The low expression rates of GAS5 and miR-424 in cervical cancer patients with metastasis or FIGO type Ⅱb-Ⅲa were higher than those in patients without metastasis, type Ⅰb-Ⅱa patients. The mRNA expressions of GAS5 and miR-424 in HeLa cells were lower than those in Ect1/E6E7 cells (P<0.05). Compared with the negative control group, GAS5, miR-424 mRNA, apoptosis rate, Dnmts and EZH2 expression in HeLa cells decreased in GAS5 RNAi group, but increased in GAS5 plasmid group; cell proliferation rate and Akt3 expression in GAS5 RNAi group increased, but decreased in GAS5 plasmid group (P<0.05). ConclusionLong non-coding RNA GAS5 inhibits the proliferation of cervical cancer HeLa cells by targeting the expression of miR-424.